Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2011-10-04 Proxy Solicitation & In…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Official notification of AGM 74 pages 406.7KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'DEF 14A Definitive proxy statements' and is filed with the SEC. It contains detailed information about the annual meeting of stockholders, including election of directors, executive compensation, amendments to incentive plans, and ratification of auditors. The text includes voting instructions, meeting details, and comprehensive proxy materials. The presence of the term 'DEF 14A' and the content focused on proxy solicitation and shareholder voting clearly identifies this as a Proxy Solicitation & Information Statement filing. The document length (15,000 characters) and detailed content confirm it is the full proxy statement, not just an announcement or summary.
2011-10-04 English
Daily share buy-back notice - Appendix 3E 2 pages 55.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, and compliance statements related to the buy-back. It is a regulatory announcement about the company's share repurchase activity rather than a full financial report or earnings release. The document length is short (2216 characters) and it provides specific transactional data about share buy-backs. This fits the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback of its own shares.
2011-10-03 English
Daily share buy-back notice - Appendix 3E 2 pages 55.6KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details about the number of shares bought back, total consideration paid, and compliance statements. The document is short (2215 characters) and is a regulatory notice about share repurchase activity, not a full financial report or earnings release. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buyback activities. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is POS with high confidence.
2011-10-03 English
Daily share buy-back notice - Appendix 3E 2 pages 55.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, and compliance statements. The document is short (2217 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. It matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. There is no indication that this is an announcement of a report publication or a regulatory certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2011-09-29 English
Daily share buy-back notice - Appendix 3E 2 pages 55.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details about the number of shares bought back, total consideration paid, and compliance statements. The document is short (2272 characters) and is a regulatory notice about share buy-back activity, not a full financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2011-09-28 English
Daily share buy-back notice - Appendix 3E 2 pages 55.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX (Australian Securities Exchange). It details the number of shares bought back, total consideration paid, and compliance statements related to the buy-back. It is a regulatory announcement about the company's share repurchase activity rather than a full financial report or earnings release. The document length is short (2217 characters) and it contains specific buy-back data, which fits the definition of a Transaction in Own Shares (POS) filing. Therefore, the correct classification is POS.
2011-09-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.